New ultra-short acting hypnotic: synthesis, biological evaluation, and metabolic profile of ethyl 8-oxo-5,6,7,8-tetrahydro-thiazolo[3,2-a][1,3]diazepin-3-carboxylate (HIE-124)

Bioorg Med Chem Lett. 2008 Jan 1;18(1):72-7. doi: 10.1016/j.bmcl.2007.11.011. Epub 2007 Nov 7.

Abstract

Ethyl 8-oxo-5,6,7,8-tetrahydro-thiazolo[3,2-a][1,3]diazepin-3-carboxylate (HIE-124, 4) is a member of a new generation of ultra-short acting hypnotics. HIE-124 (4) exhibited potent in vivo activity with a rapid onset of action and a short duration of action, with no acute tolerance or noticeable side effects. The metabolic profile of 4 is also performed. HIE-124 (4) has the potential use as a preanesthetic medication, anesthesia inducer, and could be used with thiopental sodium to maintain anesthesia for longer duration.

MeSH terms

  • Animals
  • Azepines / metabolism*
  • Azepines / pharmacokinetics
  • Azepines / pharmacology*
  • Carboxylic Acids / metabolism*
  • Carboxylic Acids / pharmacokinetics
  • Carboxylic Acids / pharmacology*
  • Dose-Response Relationship, Drug
  • Hypnotics and Sedatives / chemical synthesis
  • Hypnotics and Sedatives / metabolism*
  • Hypnotics and Sedatives / pharmacokinetics
  • Hypnotics and Sedatives / pharmacology*
  • Mice
  • Thiazoles / metabolism*
  • Thiazoles / pharmacokinetics
  • Thiazoles / pharmacology*

Substances

  • 8-oxo-5,6,7,8-tetrahydro-thiazolo(3,2-a)(1,3)diazepin-3-carboxylate
  • Azepines
  • Carboxylic Acids
  • Hypnotics and Sedatives
  • Thiazoles